Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-05-27
1988-08-30
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544 44, 544 46, A61K 3147, C07D49108
Patent
active
047677643
ABSTRACT:
Alkoxyalkyl and alkylmercaptoalkyl substituted bridged benzofuroisoquinolines have opioid antagonist, and/or appetite-controlling properties. Preferred compounds are kappa receptor selective antagonists. Examples of such preferred compounds are 5-Methoxymethyl-3-n-propyl- 1,2,3,4,5,6,7,7a-octahydro-4a,7-ethanobenzofuro[3,2-e]isoquinolin-9-ol and 3-Cyclopropylmethyl-5-methoxymethyl-1,2,3,4,5,6,7,7a-octahydro-4a,7-ethano benzofuro[3,2-e]isoquinoline-9-ol.
REFERENCES:
patent: 4477456 (1984-10-01), Ciganek
Daus Donald G.
E. I. Du Pont de Nemours and Company
Rivers Diana G.
LandOfFree
Alkoxyalkyl and alkylmercaptoalkyl substituted bridged benzofuro does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkoxyalkyl and alkylmercaptoalkyl substituted bridged benzofuro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkoxyalkyl and alkylmercaptoalkyl substituted bridged benzofuro will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2088440